Xuan Luo

机构：Central South University, China Pharmaceutical University, Dalian Medical University, Second Affiliated Hospital of Chongqing Medical University, Nanjing Drum Tower Hospital, Cell Technology (China), Hainan Medical University, Chongqing Medical University · ORCID：0000-0002-0137-7681

发表论文 99 篇 · 总被引 2178 次 · h-index 27

代表论文

• Immunometabolic alteration of CD4+ T cells in the pathogenesis of primary Sjögren’s syndrome (2024 · Clinical and Experimental Medicine · 被引 18)
• Columbianadin suppresses glioblastoma progression by inhibiting the PI3K-Akt signaling pathway (2024 · Biochemical Pharmacology · 被引 12)
• Casein Kinase 1α Regulates Testosterone Synthesis and Testis Development in Adult Mice (2023 · Endocrinology · 被引 12)
• Cysteine dioxygenase and taurine are essential for embryo implantation by involving in E2-ERα and P4-PR signaling in mouse (2023 · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · 被引 12)
• Comparison of the efficacy and safety of leflunomide versus mycophenolate mofetil in treating IgG4-related disease: a retrospective cohort study (2023 · Clinical Rheumatology · 被引 11)
• Tenacissoside H repressed the progression of glioblastoma by inhibiting the PI3K/Akt/mTOR signaling pathway (2024 · European Journal of Pharmacology · 被引 8)